Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2016

Open Access 01-12-2016 | Research article

The relationship between serum fatty-acid binding protein 4 level and lung function in Korean subjects with normal ventilatory function

Authors: Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Seong Yong Lim, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee

Published in: BMC Pulmonary Medicine | Issue 1/2016

Login to get access

Abstract

Background

The aim of this study was to assess the association of lung function with serum fatty-acid binding protein 4 (FABP4) in apparently healthy Korean adults.

Methods

In 495 participants in a health screening program, Force Exploratory Volume (FEV) 1 and Forced Vital Capacity (FVC) were assessed with standard spirometry. Subjects with obstructive (n = 19) and restrictive (n = 45) lung function were excluded from the analysis. Serum FABP4 level was measured by enzyme-linked immunosorbent assay and transformed into Ln(FABP4). 431 subjects with normal ventilator function (72.4 % men, mean age 41 years) were included in the final analysis.

Results

Mean Ln(FABP4) significantly decreased in subjects from 1st quartile to 4th quartile of FVC (p = 0.008). Ln(FABP4) did not show significant differences across the quartile groups of FEV1. The odds ratio (OR) of being in the lowest quartile of FVC was 2.704 in subject with 3rd tertile of Ln(FABP4) after full adjustment for confounding variables {95 % confidence interval (CI) 1.397 ~ 5.357}. OR of being in the lowest quartile of FEV1 was 1.822 (95 % CI 1.021 ~ 3.298) in subjects with 3rd tertile of Ln(FABP4) after adjustment of age and sex, which was attenuated after full adjustment for confounding variables.

Conclusion

Increased FABP4 level showed increased risk for reduced lung function in subjects with normal ventilatory function.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14(6):561–6.CrossRefPubMed Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14(6):561–6.CrossRefPubMed
3.
go back to reference Ouchi N, Ohashi K, Shibata R, Murohara T. Adipocytokines and obesity-linked disorders. Nagoya J Med Sci. 2012;74(1–2):19–30.PubMed Ouchi N, Ohashi K, Shibata R, Murohara T. Adipocytokines and obesity-linked disorders. Nagoya J Med Sci. 2012;74(1–2):19–30.PubMed
4.
go back to reference Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2001;11(2):85–97.CrossRef Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2001;11(2):85–97.CrossRef
6.
go back to reference Luo FM, Liu XJ, Li SQ, Wang ZL, Liu CT, Yuan YM. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition. 2005;21(7–8):793–8.CrossRefPubMed Luo FM, Liu XJ, Li SQ, Wang ZL, Liu CT, Yuan YM. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition. 2005;21(7–8):793–8.CrossRefPubMed
7.
go back to reference Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113(9):1318–27.PubMedCentralCrossRefPubMed Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113(9):1318–27.PubMedCentralCrossRefPubMed
8.
go back to reference Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004;47(2):195–203.CrossRefPubMed Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004;47(2):195–203.CrossRefPubMed
9.
go back to reference Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010;25(10):1480–6.PubMedCentralCrossRefPubMed Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010;25(10):1480–6.PubMedCentralCrossRefPubMed
10.
go back to reference Kim SK, Hur KY, Choi YH, Kim SW, Chung JH, Kim HK, et al. The Relationship between Lung Function and Metabolic Syndrome in Obese and Non-Obese Korean Adult Males. Korean Diabetes J. 2010;34(4):253–60.PubMedCentralCrossRefPubMed Kim SK, Hur KY, Choi YH, Kim SW, Chung JH, Kim HK, et al. The Relationship between Lung Function and Metabolic Syndrome in Obese and Non-Obese Korean Adult Males. Korean Diabetes J. 2010;34(4):253–60.PubMedCentralCrossRefPubMed
11.
go back to reference Oda E, Kawai R. A cross-sectional relationship between vital capacity and diabetes in Japanese men. Diabetes Res Clin Pract. 2009;85(1):111–6.CrossRefPubMed Oda E, Kawai R. A cross-sectional relationship between vital capacity and diabetes in Japanese men. Diabetes Res Clin Pract. 2009;85(1):111–6.CrossRefPubMed
12.
go back to reference Oda E, Kawai R. A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population. Environ Health Prev Med. 2009;14(5):284–91.PubMedCentralCrossRefPubMed Oda E, Kawai R. A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population. Environ Health Prev Med. 2009;14(5):284–91.PubMedCentralCrossRefPubMed
13.
go back to reference Garin-Shkolnik T, Rudich A, Hotamisligil GS, Rubinstein M. FABP4 attenuates PPARgamma and adipogenesis and is inversely correlated with PPARgamma in adipose tissues. Diabetes. 2014;63(3):900–11.CrossRefPubMed Garin-Shkolnik T, Rudich A, Hotamisligil GS, Rubinstein M. FABP4 attenuates PPARgamma and adipogenesis and is inversely correlated with PPARgamma in adipose tissues. Diabetes. 2014;63(3):900–11.CrossRefPubMed
14.
go back to reference Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 2009;23(11):3865–73.PubMedCentralCrossRefPubMed Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 2009;23(11):3865–73.PubMedCentralCrossRefPubMed
15.
go back to reference Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis (Seoul). 2005;58(3):230–42.CrossRef Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis (Seoul). 2005;58(3):230–42.CrossRef
16.
go back to reference Curb JD, Ford C, Hawkins CM, Smith EO, Zimbaldi N, Carter B, et al. A coordinating center in a clinical trial: the Hypertension Detection and Followup Program. Control Clin Trials. 1983;4(3):171–86.CrossRefPubMed Curb JD, Ford C, Hawkins CM, Smith EO, Zimbaldi N, Carter B, et al. A coordinating center in a clinical trial: the Hypertension Detection and Followup Program. Control Clin Trials. 1983;4(3):171–86.CrossRefPubMed
17.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed
19.
go back to reference Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128(3):501–6.CrossRefPubMed Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128(3):501–6.CrossRefPubMed
20.
go back to reference Maiolo C, Mohamed EI, Carbonelli MG. Body composition and respiratory function. Acta Diabetol. 2003;40 Suppl 1:S32–8.CrossRefPubMed Maiolo C, Mohamed EI, Carbonelli MG. Body composition and respiratory function. Acta Diabetol. 2003;40 Suppl 1:S32–8.CrossRefPubMed
21.
go back to reference Cotes JE, Chinn DJ, Reed JW. Body mass, fat percentage, and fat free mass as reference variables for lung function: effects on terms for age and sex. Thorax. 2001;56(11):839–44.PubMedCentralCrossRefPubMed Cotes JE, Chinn DJ, Reed JW. Body mass, fat percentage, and fat free mass as reference variables for lung function: effects on terms for age and sex. Thorax. 2001;56(11):839–44.PubMedCentralCrossRefPubMed
22.
go back to reference Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111(4):891–8.CrossRefPubMed Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111(4):891–8.CrossRefPubMed
23.
go back to reference Santana H, Zoico E, Turcato E, Tosoni P, Bissoli L, Olivieri M, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr. 2001;73(4):827–31.PubMed Santana H, Zoico E, Turcato E, Tosoni P, Bissoli L, Olivieri M, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr. 2001;73(4):827–31.PubMed
24.
go back to reference Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003.PubMed Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003.PubMed
25.
go back to reference Mancuso P. Obesity and lung inflammation. J Appl Physiol. 1985;108(3):722–8.CrossRef Mancuso P. Obesity and lung inflammation. J Appl Physiol. 1985;108(3):722–8.CrossRef
26.
go back to reference Wang C. Obesity, inflammation, and lung injury (OILI): the good. Mediat Inflamm. 2014;2014:978463. Wang C. Obesity, inflammation, and lung injury (OILI): the good. Mediat Inflamm. 2014;2014:978463.
27.
go back to reference Gurzu B, Zugun FE, Costuleanu M, Mihaescu T, Carasevici E, Petrescu G. Adipokines involvement in lung function. Rev Med Chir Soc Med Nat Iasi. 2008;112(3):719–25.PubMed Gurzu B, Zugun FE, Costuleanu M, Mihaescu T, Carasevici E, Petrescu G. Adipokines involvement in lung function. Rev Med Chir Soc Med Nat Iasi. 2008;112(3):719–25.PubMed
28.
go back to reference Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118:2640–50.PubMedCentralPubMed Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118:2640–50.PubMedCentralPubMed
29.
go back to reference Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959–65. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959–65.
30.
go back to reference Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274(5291):1377–9.CrossRefPubMed Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274(5291):1377–9.CrossRefPubMed
31.
go back to reference Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005;1(2):107–19.CrossRefPubMed Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005;1(2):107–19.CrossRefPubMed
32.
go back to reference Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7(6):699–705.PubMedCentralCrossRefPubMed Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7(6):699–705.PubMedCentralCrossRefPubMed
33.
go back to reference Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J Clin Endocrinol Metab. 2012;97(1):E1943–7.PubMedCentralCrossRefPubMed Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J Clin Endocrinol Metab. 2012;97(1):E1943–7.PubMedCentralCrossRefPubMed
34.
go back to reference Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest. 2006;36(9):621–5.CrossRefPubMed Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest. 2006;36(9):621–5.CrossRefPubMed
35.
go back to reference Jeon WS, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, et al. Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab (Seoul). 2013;28(4):283–7.CrossRef Jeon WS, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, et al. Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab (Seoul). 2013;28(4):283–7.CrossRef
36.
go back to reference Lee TH, Jeon WS, Han KJ, Lee SY, Kim NH, Chae HB, et al. Comparison of Serum Adipocytokine Levels according to Metabolic Health and Obesity Status. Endocrinol Metab (Seoul). 2015;30(2):185-94. Lee TH, Jeon WS, Han KJ, Lee SY, Kim NH, Chae HB, et al. Comparison of Serum Adipocytokine Levels according to Metabolic Health and Obesity Status. Endocrinol Metab (Seoul). 2015;30(2):185-94.
37.
go back to reference Lin WY, Yao CA, Wang HC, Huang KC. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring). 2006;14(9):1654–61.CrossRef Lin WY, Yao CA, Wang HC, Huang KC. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring). 2006;14(9):1654–61.CrossRef
38.
go back to reference Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008;134(4):712–8.CrossRefPubMed Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008;134(4):712–8.CrossRefPubMed
Metadata
Title
The relationship between serum fatty-acid binding protein 4 level and lung function in Korean subjects with normal ventilatory function
Authors
Hye-Jeong Park
Se Eun Park
Cheol-Young Park
Seong Yong Lim
Won-Young Lee
Ki-Won Oh
Sung-Woo Park
Eun-Jung Rhee
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2016
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-016-0190-8

Other articles of this Issue 1/2016

BMC Pulmonary Medicine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.